Improved lipid target level attainment in patients with peripheral artery disease - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33430734/

It appears that there is more awareness and improvement of previously documented undertreatment of LDL-C levels in symptomatic PAD patients. Although statin treatment is initiated in the majority of patients, our findings call for a continuously intensified LLT in symptomatic PAD patients.